Stock of the Day

November 22, 2019

Merit Medical Systems (MMSI)

$73.99
-$1.56 (-2.1%)
Market Cap: $4.51B

About Merit Medical Systems

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Today's Trend

Merit Medical Systems, Inc. (NASDAQ: MMSI) has been under pressure after a recent pullback in the shares, but several analyst estimate revisions and a bullish research note may be helping support the stock. The latest headlines point to a mixed setup: investors are reacting to a weaker near-term earnings outlook, while longer-term forecasts have improved.

  • Zacks Research raised its earnings estimates for Merit Medical Systems in several future periods, including FY2026, Q4 2026, Q3 2027, Q1 2028, and FY2028, signaling improved longer-term profit expectations for the medical instruments supplier. Merit Medical Systems analyst estimate revisions
  • A Zacks-style growth article highlighted Merit Medical as a potential long-term growth stock, which may reinforce investor interest in the company’s fundamentals. Merit Medical Systems long-term growth article
  • One market update said short interest in Merit Medical Systems was reported at zero shares, so the data did not show a meaningful new bearish positioning signal.
  • The stock recently fell 3.1% in a separate market note, reflecting continued weakness and broader concern after a sizable decline from recent levels. Merit Medical Systems shares fall 3.1%
  • Despite the positive estimate revisions, Zacks Research also cut its Q2 2026 EPS estimate, suggesting some near-term earnings pressure remains.

Overall, MMSI appears to be moving on a mix of better long-term earnings expectations and near-term stock weakness. The analyst upgrades are the main constructive driver, but the lowered Q2 outlook and recent share decline show investors are still cautious about the next few quarters.

← Previous Stock of the DayNext Stock of the Day →